Clinical Trials Browser

Interventional × Melanoma × endostar protein × Clear all

NCT06965231 2025-05-11

FUMS-EDJS2024

Phase 2 Recruiting

Melanoma

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

Phase 2 Unknown

Melanoma